Insider buy
$Summit Therapeutics(SMMT.US$ Ankur Dhingra, Chief Financial Officer, on March 26, 2024, executed a purchase for 100,000 shares in Summit Therapeutics (SMMT) for $375,000. Following the Form 4 filing with the SEC, Dhingra has control over a total of 354,958 shares of the company, with 354,958 shares controlled indirectly.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
SlowndEasyTrades : GRabed few here
TrytosaveabitOP SlowndEasyTrades: I think it will end up being a decent swing! GL
SlowndEasyTrades TrytosaveabitOP: It’s not real swing trade sell at resistance longer hold type small bet only I don’t like swing trade below 5$ valuation anyway
TrytosaveabitOP SlowndEasyTrades: I consider anything longer than a day, a swing! Whether I’m looking for bottom to buy and hold for data/PR/deal! And could hold for 6/8+ weeks! Others swings are severely OS ATL/Near ATL/52WKL with a chart that’s saying reversal coming!
SlowndEasyTrades TrytosaveabitOP: Great insight thanks !
TrytosaveabitOP SlowndEasyTrades: You’re welcome!